COVID-19 CDC Update – Early January 2022
COVID-19 CDC Update – Early January 2022
Former CDC Executive Secretariat of the Advisory Committee on Immunization Practices Amanda Cohn, MD, joins JAMA Associate Editor Preeti Malani, MD, for the latest on the need for vaccination and boosters, vaccine misinformation, and tackling the pandemic from a global perspective. Recorded January 6, 2022.Topics discussed in this interview:
0:00 Intro
0:06 Guest introduction
1:56 A discussion of the statement, "vaccines don't save lives, vaccinations do."
4:34 Discussing barriers to vaccine access
6:03 Discussing barriers to vaccination
8:32 Johnson & Johnson/Janssen vaccines in the United States
11:30 Status of vaccine approvals for those under 5 years of age
14:40 Evolution of guidance on vaccinations
21:15 Criticisms of constantly changing guidelines
21:51 What data will CDC be paying attention to for future booster guidance or 4th doses?
23:30 Goals of the vaccination program
26:15 Information and misinformation
29:23 Patient trust and addressing patient concerns
32:55 Global vaccination efforts and vaccine equity
37:06 What may come next?
40:23 Credits
Link to read the JAMA Viewpoint: https://ja.ma/3HP1lDa
Link to listen to the podcast: https://ja.ma/3fqNRBz
Link to read the related JAMA Medical News article: https://ja.ma/3fbInKI
• Coronavirus Resource page from the JAMA Network: https://ja.ma/covidyt
• To watch all the #JAMALive Q&A's Visit: https://ja.ma/covidqaytpl
• Don't forget to hit subscribe or click https://ja.ma/subscribe
---------------------------------------------------------------------------------
For more from JAMA
• https://www.jama.com
• https://www.facebook.com/JAMAJournal
• https://www.twitter.com/JAMA_Current
• https://www.linkedin.com/company/jamanetwork
Follow the JAMA Network
• https://www.jamanetwork.com
• http://www.jamanetworkaudio.com
• https://www.facebook.com/JAMANetwork
• https://www.twitter.com/JAMANetwork
• https://www.instagram.com/JAMANetwork
• https://www.pinterest.com/JAMANetwork
=====================================================================
#JAMALive #Coronavirus #COVID19 #SARSCoV2 #Pandemic
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.